Western European Molecular Diagnostics Market, 2015 Forecast to 2020

Prevalence and Prevention Driving Healthcare in Europe Toward Molecular Diagnostics Expansion and Innovation

USD 4,950

* Required Fields

USD 4,950

PAY BY INVOICE

Be the first to review this product

Across all segments of in-vitro diagnostics, including research and further upcoming disruptive technologies across the life sciences landscape—research tools, clinical diagnostics, and pharma—disruptive technologies transform the complete healthcare decision making and diagnostics trend. However, to take advantage of these opportunities and maintain a competitive advantage, life science companies must be able to develop a thorough holistic understanding of areas outside their own expertise to leverage the cross-functional trends and synergistic growth opportunities that are available. Molecular diagnostics companies that fail to capitalize on the opportunities presented through emerging trends and disruptive new business models become late entrants in a market, generally before redundancy from me-too products occurs and take market share. This study provides an elaborate structure of the European healthcare system , which is supporting the growth of molecular diagnostics, the reimbursement strategies, and policies promoting the acceptance of MDx assays across applications. This information would be suitable to understand the current need and the diagnostics style adoption among the patient population for better outcomes and clinical decision making. Specific challenges shared in this study include the shifting payment landscape which pays for services, change in business models, and challenges in innovative therapeutics and molecular diagnostics to align with value-based care models.

Table of Contents

1. Executive Summary
Market Snapshot
Executive summary
Scope and Segmentation
Executive Summary—Market Engineering Measurements
Big Market Directions in Molecular Diagnostics
2. Market Overview
Market Definition
Expansion of Molecular Diagnostics
Molecular Technologies in IVD—Growth Trends by Segment
Trends Impacting the Molecular Diagnostics Market
Molecular Diagnostics Value Chain—Redefine Patient Care
Molecular Diagnostics—One of the Fastest Growing Segments in the IVD Industry
Promising Factors for the Growth of Molecular Diagnostics in Europe
Key Companies to Watch
3. Technology Overview
Evolution of Science irecting Toward Revolutionizing Molecular Technologies
MDx Action Framework Driving Clinical Decision Making and Betterment in Treatment Provision
Action Framework of MDx in a Testing Scenario
Genomic Biomarker—Defining the MDx Spectrum
Genomic Biomarker—Defining the Diagnostics Spectrum
Workflow of Molecular Diagnostic Techniques
Molecular profiling Across diseases
Parameters Monitoring the Effectiveness of the MDx Platform
New Technologies Overlap Molecular Diagnostics Testing Across Technology
PCR—Gold Standard of Molecular Diagnostics
Key Technologies to Watch
4. European Molecular Diagnostics Market Dynamics
EU Regulatory Bodies for IVD and MDx in European Countries
Reduction of Overall Healthcare Expenditure Toward Early Diagnosis
Healthcare Spending in Europe Rising Faster Than Economic Growth
Market Access Pathways—Molecular Diagnostics
Key Success Criteria in the Molecular Diagnostics Market
Assessing the Value of Molecular Diagnostics in Europe
Major Factors that Govern the Molecular Diagnostics Assessment by HTA Across European Countries
Stepping Stones Promoting Molecular Diagnostics Among the Public With Government Backing
Europe Presents Specific Inter- and Intra-national Heterogeneity in Terms of Diagnostic Reimbursement
Molecular Diagnosis, Resulting in Preventive Rather Than Reactive Healthcare
Entry Barriers to Personalized Medicine in Europe
5. Drivers and Restrains—Total Molecular Diagnostics Market
Market Drivers
Market Restraints
6. Forecasts and Trends—Total Molecular Diagnostics Market
Market Engineering Measurements
Revenue Forecast
Revenue Share by Region
7. Competitive Landscape
Market Share by Top Competitors
Comparison of Molecular Diagnostic Techniques
Competitor MDx Platforms Available Across Application
NGS Conquering the Future Space of Molecular Diagnostics
The Release of Ilumina’s HiSeq X Ten has Reduced the Cost of Sequencing a Human Genome to US$1,000
8. Mergers and Acquisitions
Merger, Acquisition, and Partnership Assessment
9. Molecular Diagnostics Infectious Disease Market Analysis
Revenue Forecast
MDx Platforms Commercially Available for Infectious Diseases
Commercially Available Assay for STI-based Pathogens Across Europe
10. Genetic Testing Market Analysis
Revenue Forecast
Emerging Opportunity—Non-invasive Prenatal Testing Across Europe
11. Pharmacogenomics Market Analysis
Revenue Forecast
Paradigm Shifts in Treatment
Implication of Pharmacogenomics
Highest-ranking Barriers to Implementing the Use of Pharmacogenomics Testing in Europe
12. Oncology Market Analysis
Revenue Forecast
Uptake of Oncology in Biomarker Testing Across the EU
Implication of Oncology
13. Molecular Diagnostics Segment-wise Market Analysis
Market Share Across Technology Segments
Market Share Across Application Segments
Western Europe Molecular Diagnostics Application Segment Metrics Analysis
Western Europe Molecular Diagnostics Technology Segment Metrics Analysis
14. The United Kingdom Analysis
Revenue Forecast
15. Germany Analysis
Revenue Forecast
16. France Analysis
Revenue Forecast
17. Italy Analysis
Revenue Forecast
18. Spain Analysis
Revenue Forecast
19. Benelux Analysis
Revenue Forecast
20. Scandinavia Analysis
Revenue Forecast
21. Key Participants
Roche Diagnostics
Illumina
Cepheid
The Last Word
5 Major Growth Opportunities
Strategic Imperatives for Success and Growth
22. Last Word
Conclusion
Legal Disclaimer
Market Engineering Methodology
23. Appendix
24. List of Companies
25. CE Marked Approved Assays
CE Marked Assays 2015 and 2016
CE Marked Approved Assays 2015 and 2016
Drivers Explained
Restrains Explained

Infographic



List of Figures & Charts

1. Total Molecular Diagnostics Market: Market Trends, Western Europe, 2015
2. Total Molecular Diagnostics Market: MDx Technology Application, Western Europe, 2015
3. Total Molecular Diagnostics Market: Future Key Opportunities and Current Status of MDx, Western Europe, 2015
4. Total Molecular Diagnostics Market: Technology Segmentation, Western Europe, 2015
5. Total Molecular Diagnostics Market: Need for Molecular Diagnostics Across the Patient Continuum, Western Europe, 2015
6. Total Molecular Diagnostics Market: Companies to Watch, Western Europe, 2015
7. Total Molecular Diagnostics Market: Evolution Timeline, Global, 1952–2015
8. Total Molecular Diagnostics Market: Action Framework in Molecular Diagnostics, Western Europe, 2015
9. Total Molecular Diagnostics Market: Action Framework in Molecular Diagnostics, Western Europe, 2015
10. Total Molecular Diagnostics Market: Work Flow, Global, 2015
11. Total Molecular Diagnostics Market: Molecular Profiling—Biomarker Testing, Western Europe, 2015
12. Total Molecular Diagnostics Market: Effectiveness Across Platforms, Global, 2015
13. Total Molecular Diagnostics Market: Overlapping MDx Testing, Global, 2015
14. MDx Technology Polymerase Chain Reaction Variant Comparison, Global, 2015
15. Total Molecular Diagnostics Market: Technologies to Watch, Western Europe , 2015
16. Total Molecular Diagnostics Market: Regulatory Bodies, Western Europe, 2015
17. Total Molecular Diagnostics Market: National Healthcare System, EU, 2015
18. Total Molecular Diagnostics Market: EU 5 Regional Laboratory Facility Norms Inferences, EU, 2015
19. Total Molecular Diagnostics Market: Market Access Pathway, Western Europe, 2015
20. Total Molecular Diagnostics Market: Growth Opportunities in MDx Business Terms, Western Europe, 2015
21. Total Molecular Diagnostics Market: Assay Assessment by HTA, Western Europe, 2015
22. Total Molecular Diagnostics Market: Healthcare Structure, Western Europe, 2015
23. Total Molecular Diagnostics Market: Diagnostics Reimbursement, Europe, 2015
24. Total Molecular Diagnostics Market: MDx in Preventive Healthcare, Western Europe, 2015–2020
25. Total Molecular Diagnostics Market: Policy Making Regulations, Western Europe, 2015
26. Total Molecular Diagnostics Market: Key Market Drivers, Western Europe, 2016–2020
27. Total Molecular Diagnostics Market: Key Market Restraints, Western Europe, 2016–2020
28. Molecular diagnostics Market : Market Engineering Measurements, Western Europe, 2015
29. Total Molecular Diagnostics Market: Pros and Cons of Microarray and FISH, Global, 2015
30. Molecular Diagnostics Market: Pros and cons of NGS and PCR, Global, 2015
31. Total Molecular Diagnostics Market: Competitor Application Platform, Western Europe, 2015
32. Total Molecular Diagnostics Market: Pros and Cons of Various NGS Platforms, Western Europe, 2015
33. Total Molecular Diagnostics Market: Notable Deals and Market Impact, Western Europe, 2015 and 2016
34. Total Molecular Diagnostics Market: Infectious Disease Threat Scenarios, European Union, 2020
35. Total Molecular Diagnostics Market: Currently Available MDx Platforms for Infectious Diseases, Europe, 2015
36. Total Molecular Diagnostics Market: Currently Available Assay for Sexually Transmitted Diseases, Western Europe, 2015
37. Molecular Diagnostics Genetic Testing Market: NIPT Spectrum, Western Europe, 2015
38. Total Molecular Diagnostics Market: Barriers in Pharmacogenomics, Western Europe, 2015
39. Molecular Diagnostics Market: Emerging Molecular Diagnostic Tests Trends in Oncology, Western Europe , 2015
40. Total Molecular Diagnostics Market: Technology Metric Analysis, Western Europe, 2015
41. Total Molecular Diagnostics Market: Application Metric Analysis, Western Europe, 2015
42. Total Molecular Diagnostics Market: Company Profile—Roche Diagnostics, Western Europe, 2015
43. Total Molecular Diagnostics Market: Company Pipeline—Roche Diagnostics, Western Europe, 2015
44. Total Molecular Diagnostics Market: Company Profile—Illumina, Western Europe, 2015
45. Total Molecular Diagnostics Market: Company Profile—Cepheid, Western Europe, 2015


1. Total Molecular Diagnostics Market: Market Engineering Measurements, Western Europe, 2015
2. Total In Vitro Diagnostics Market: Growth by Segment, Western Europe, 2015
3. Total Molecular Diagnostics Market: Growth Factors, Western Europe, 2016–2020 and Beyond
4. IVD Spending Comparison, Germany, 2007 and 2013
5. Total Molecular Diagnostics Market: Revenue Forecast, Western Europe, 2013–2020
6. Total Molecular Diagnostics Market: Percent Revenue by Region, Western Europe, 2015
7. Total Molecular Diagnostics Market: Percent Revenue Breakdown, Western Europe, 2015
8. Molecular Diagnostics Infectious Disease Market: Revenue Forecast, Western Europe, 2013–2020
9. Molecular Diagnostics Genetic Testing Market: Revenue Forecast, Western Europe, 2013–2020
10. Molecular diagnostics Pharmacogenomics Market: Revenue Forecast, Western Europe, 2013–2020
11. Molecular Diagnostics Oncology Market: Revenue Forecast, Western Europe, 2013–2020
12. Total Molecular Diagnostics Market: Percent Revenue Breakdown by Technology, Western Europe, 2015
13. Total Molecular Diagnostics Market: Percent Revenue Breakdown by Application, Western Europe, 2015
14. Molecular Diagnostics Market: Revenue Forecast, The United Kingdom, 2013–2020
15. Molecular Diagnostics Market: Revenue Forecast, Germany, 2013–2020
16. Molecular Diagnostics Market: Revenue Forecast, France, 2013–2020
17. Molecular Diagnostics Market: Revenue Forecast, Italy, 2013–2020
18. Molecular Diagnostics Market: Revenue Forecast, Spain, 2013–2020
19. Molecular Diagnostics Market: Revenue Forecast, Benelux, 2013–2020
20. Molecular Diagnostics Market: Revenue Forecast, Scandinavia, 2013–2020



Keyword1

Keyword2

Keyword3

Related Research

Release Date : 07-Nov-17

Region : North America

Release Date : 31-Oct-17

Region : North America

Release Date : 17-Jul-17

Region : North America

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.